These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17610521

  • 1. DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.
    Kunitz A, Wolter M, van den Boom J, Felsberg J, Tews B, Hahn M, Benner A, Sabel M, Lichter P, Reifenberger G, von Deimling A, Hartmann C.
    Brain Pathol; 2007 Oct; 17(4):363-70. PubMed ID: 17610521
    [Abstract] [Full Text] [Related]

  • 2. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M, Dávalos V, Ropero S, Setién F, Paz MF, Herranz M, Fraga MF, Mora J, Cheung NK, Gerald WL, Esteller M.
    Cancer Res; 2005 Apr 01; 65(7):2565-71. PubMed ID: 15805250
    [Abstract] [Full Text] [Related]

  • 3. EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q.
    Li KK, Pang JC, Chung NY, Ng YL, Chan NH, Zhou L, Poon WS, Ng HK.
    Int J Cancer; 2007 Feb 15; 120(4):947-50. PubMed ID: 17187361
    [Abstract] [Full Text] [Related]

  • 4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 5. LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.
    Pasini A, Iorio P, Bianchi E, Cerasoli S, Cremonini AM, Faedi M, Guarnieri C, Guiducci G, Riccioni L, Molinari C, Rengucci C, Calistri D, Giordano E.
    Oncol Rep; 2012 Dec 01; 28(6):2271-7. PubMed ID: 22992787
    [Abstract] [Full Text] [Related]

  • 6. Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.
    Mellai M, Piazzi A, Caldera V, Annovazzi L, Monzeglio O, Senetta R, Cassoni P, Schiffer D.
    Biomed Res Int; 2013 Dec 01; 2013():756302. PubMed ID: 24083241
    [Abstract] [Full Text] [Related]

  • 7. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.
    Tews B, Felsberg J, Hartmann C, Kunitz A, Hahn M, Toedt G, Neben K, Hummerich L, von Deimling A, Reifenberger G, Lichter P.
    Int J Cancer; 2006 Aug 15; 119(4):792-800. PubMed ID: 16550607
    [Abstract] [Full Text] [Related]

  • 8. Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.
    Huang L, Jiang T, Yuan F, Li GL, Cui Y, Liu EZ, Wang ZC.
    Neuropathol Appl Neurobiol; 2009 Aug 15; 35(4):367-379. PubMed ID: 19019173
    [Abstract] [Full Text] [Related]

  • 9. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L, Jiang T, Yuan F, Li GL, Xu LX, Cui Y.
    Zhonghua Zhong Liu Za Zhi; 2011 Oct 15; 33(10):752-8. PubMed ID: 22335907
    [Abstract] [Full Text] [Related]

  • 10. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan 15; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
    Hong C, Maunakea A, Jun P, Bollen AW, Hodgson JG, Goldenberg DD, Weiss WA, Costello JF.
    Cancer Res; 2005 May 01; 65(9):3617-23. PubMed ID: 15867356
    [Abstract] [Full Text] [Related]

  • 15. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
    Tepel M, Roerig P, Wolter M, Gutmann DH, Perry A, Reifenberger G, Riemenschneider MJ.
    Int J Cancer; 2008 Nov 01; 123(9):2080-6. PubMed ID: 18709645
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
    Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB.
    Oncogene; 1999 Jul 15; 18(28):4144-52. PubMed ID: 10435596
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.